TESARO Announces Participation in Two Investor Conferences
November 22 2017 - 4:05PM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, today announced its participation in two upcoming investor
conferences. The two conferences are:
- The Citi 2017 Global Healthcare Conference at the Lotte
New York Palace in New York, New York on Thursday, December
7. Lonnie Moulder, CEO of TESARO, and Mary Lynne Hedley,
Ph.D., President and COO of TESARO, will participate in an
analyst-led moderated Q&A from 1:25 to 2:05 PM ET and in
meetings with investors.
- The Guggenheim Securities 5th Annual Boston Healthcare
Conference at the Intercontinental in Boston, Massachusetts on
Wednesday, December 13. Tim Pearson, Executive Vice
President and CFO of TESARO, will participate in meetings with
investors.
A live webcast of the analyst-led Q&A
discussion at the Citi conference will be available by visiting the
Investors section of the TESARO website at www.tesarobio.com. An
archived replay of this webcast will be available on the Company’s
website for 14 days following the conference.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
For additional information, please
contact: Jennifer DavisVice President,
Corporate Communications & Investor
Relations1.781.325.1116jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024